Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Amarasinghe, NY
Kande Kankanamalage Amarasinghe, Latham, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090143587 | INTERMEDIATES FOR ALPHA-FLUOROALKYL TETRABENAZINE AND DIHYDROTETRABENAZINE IMAGING AGENTS AND PROBES - The present invention provides novel fluorophilic compounds having structure VII | 06-04-2009 |
Kande Kankanamalage Dayarathna Amarasinghe, Latham, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090110636 | FLUORINATED DIHYDROTETRABENAZINE ETHER IMAGING AGENTS AND PROBES - The present invention provides novel fluorinated ether compounds having structure I | 04-30-2009 |
| 20090111990 | INTERMEDIATES FOR FLUORINATED DIHYDROTETRABENAZINE ETHER IMAGING AGENTS AND PROBES - The present invention provides novel fluorophilic compounds having structure VI | 04-30-2009 |
| 20090142265 | ALPHA-FLUOROALKYL TETRABENAZINE AND DIHYDROTETRABENAZINE IMAGING AGENTS AND PROBES - The present invention provides novel alpha-fluoroalkyl compounds having structure I and the corresponding dihydrotetrabenazine compounds IV | 06-04-2009 |
| 20090142276 | ALPHA-FLUOROALKYL DIHYDROTETRABENAZINE IMAGING AGENTS AND PROBES - The present invention provides novel alpha-fluoroalkyl dihydrotetrabenazine compounds I | 06-04-2009 |
| 20090149654 | INTERMEDIATES FOR FLUORINATED TETRABENAZINE CARBINOL COMPOUNDS IMAGING AGENTS AND PROBES - The present invention provides novel fluorophilic compounds having structure VII | 06-11-2009 |
| 20100272641 | LABELED MOLECULAR IMAGING AGENTS, METHODS OF MAKING AND METHODS OF USE - Imaging agents that comprise labeled substrates of the cystine/glutamate antiporter of cells, whereby the methods of use comprise introducing the labeled agents into cells via the cystine/glutamate antiporter, which are then reduced to a labeled cysteine, and subsequently detected in the cell. | 10-28-2010 |
| 20110206609 | FLUOROALKYL TETRABENAZINE CARBINOL COMPOUNDS AS IMAGING AGENTS AND PROBES - The present invention provides novel fluoroalkyl tetrabenazine carbinol compounds having structure I | 08-25-2011 |
Kande Kankananamalage Dayarathna Amarasinghe, Latham, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20080306267 | METHOD FOR MAKING TETRABENAZINE COMPOUNDS - A method of preparing a tetrabenazine compound (TBZ compound) having structure I comprising the steps of reacting a nucleophilic alkenyl species with aldehyde compound II and oxidizing the resultant allylic alcohol to provide enone III. The protecting group P | 12-11-2008 |
| 20080306269 | INTERMEDIATES USEFUL FOR MAKING TETRABENAZINE COMPOUNDS - A method of preparing a tetrabenazine compound (TBZ compound) having structure I comprising the steps of reacting a nucleophilic alkenyl species with aldehyde compound II and oxidizing the resultant allylic alcohol to provide enone III. The protecting group P | 12-11-2008 |
Kande K.d. Amarasinghe, Latham, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100016336 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 01-21-2010 |
| 20100069448 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 03-18-2010 |
| 20110212951 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 09-01-2011 |
Kande K. D. Amarasinghe, Latham, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20120077853 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising one or more human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 03-29-2012 |
| 20120077975 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHOD OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 03-29-2012 |